N/A N=16 Randomized Double-blind Basic Science

Single Low-Dose of Supplement Amino Acid

Growth Hormone · Amino Acid

Bottom Line

View on ClinicalTrials.gov: NCT01540773 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2017

Primary outcome: Primary: Change From Baseline of Growth Hormone — 1.15; -0.48 nanograms/ml — p=0.01

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Amino acid supplement (Drug); Placebo (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Pennington Biomedical Research Center
Primary completion: Dec 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Change From Baseline of Growth Hormone	1.15; -0.48	0.01 sig
PRIMARY Area Under the Curve of Growth Hormone Over Baseline	20.43; 19.67	0.04 sig
SECONDARY Insulin-like Growth Factor 1	208.125; 224.375	—

Summary

The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.

Eligibility Criteria

Inclusion Criteria

healthy males and healthy females
Between 18 and 70 years

Exclusion Criteria

Pregnant or nursing
Taking any chronic medication including birth control pills.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01540773). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.